Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02923180
Brief Title: Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

First Submitted : September 9, 2016
First Submitted that Met QC Criteria : September 30, 2016
First Posted : October 4, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 19, 2019
Last Update Posted : September 23, 2019